Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19.Yang Yi, et al. Acta Pharm. Sinica B. 2022.

2023-04-28 15:13:00
Yang Yi#, Meng Zhang#, Heng Xue#, Rong Yu, Yang-Oujie Bao, Yi Kuang, Yue Chai, Wem Ma, Jing Wang, Xiaomeng Shi, Wenzhe Li, Wei Hong, Junhua Li, Elishiba Muturi, Hongping Wei, Joachim Wlodarz, Szczepan Roszak, Xue Qiao*, Hang Yang*, Min Ye*. Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19. Acta Pharm. Sinica B, 2022, 12, 4154-4164.